ValGenesis is the creator of ValGenesis Smart GxP, the life sciences industry's first fully integrated, cloud-based, AI-enabled platform for end-to-end product lifecycle digitalization. Trusted by 30 of the world's top 50 life sciences companies, our platform unifies intelligent, risk-based validation and process automation in a connected ecosystem-streamlining operations, driving compliance, and reducing risk. Purpose-built for life sciences, ValGenesis empowers global organizations to improve quality of life by accelerating the delivery of consistent, safer products.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/22/25 | $16,000,000 | Strategic |
Innovation Banking Group at Bridge Bank | undisclosed |
